Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
BHssZcEcKCtXDTpp